Company intelligence / Profile preview

Pearson

London, England, United Kingdompearson.com ↗

Ownership: Public · PSO
Employees: ~18000
Development stage: Other

Overview

Pearson is a global leader in educational content and assessments. In healthcare/life sciences, it provides validated clinical outcome assessments used widely in pharma research. In October 2024, it acquired Revibe Technologies’ digital therapeutic platform for treating children with ADHD using smartwatch-based interventions. Its COA tools are standard in many clinical trials supporting efficacy/safety endpoints.

Therapeutic areas: PsychiatryNeurology
Modalities: DeviceNon-pharmacological therapyAssessment tools
Industry: Digital Health Medical Devices

Partnerships

Not specifically listed; collaborates with pharma sponsors on COA licensing/training for trials.

Financials

Market cap: $9.4B
Total revenue: $1.8B
Enterprise value: $10.8B

Beyond the preview

Go deeper on Pearson.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pearson.

Explore the full profile